BUSINESSglobal
German BioTech iDEL Therapeutics lands €9 million to develop cancer therapeutics platform
Single source
Updated 2 hours ago
First seen March 18, 2026 07:07:02Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Dortmund-based iDEL Therapeutics announced the closing of a €9 million Seed financing, to develop a pipeline of cancer therapeutics that are delivered directly into the cytosol of tumor cells. The financing was led by BiomedVC with participation from NRW.Venture, Gründerfonds Ruhr and the KHAN Technology Transfer Fund II. “iDEL Therapeutics’ concept to unlock new cancer […] The post German BioTech iDEL Therapeutics lands €9 million to develop cancer therapeutics platform appeared first on EU-Startups.